David Zhang
@davidzhangmd.bsky.social
Studying genomics, transcriptomics, and all things data science in interstitial lung disease at Columbia University.
I’m delighted to partner with Uplifting Athletes and @teamtelomere.bsky.social! This grant will enable new research to support the 1 in 10 Americans diagnosed with a #RareDisease. Join me as #WeTackleRare at the Young Investigator Draft on Jan. 31! #YID26 bit.ly/yid2026
@columbiamed.bsky.social
@columbiamed.bsky.social
Support Young Investigator Draft 2026
We are thrilled to announce that the Young Investigator Draft will be held at the Lincoln Financial Field in Philadelphia on January 31, 2026. This is a one-of-a-kind evening, honoring incredible rare...
bit.ly
December 18, 2025 at 3:18 PM
I’m delighted to partner with Uplifting Athletes and @teamtelomere.bsky.social! This grant will enable new research to support the 1 in 10 Americans diagnosed with a #RareDisease. Join me as #WeTackleRare at the Young Investigator Draft on Jan. 31! #YID26 bit.ly/yid2026
@columbiamed.bsky.social
@columbiamed.bsky.social
Reposted by David Zhang
Genetic Associations in Non-Europeans with Pulmonary Fibrosis: Analysis of the All of Us Cohort
Key genetic risk factors of IPF are less prevalent in non-European individuals but confer similar risk of disease when present
@davidzhangmd.bsky.social
#medsky
🔗 tinyurl.com/2w8jpj9r
Key genetic risk factors of IPF are less prevalent in non-European individuals but confer similar risk of disease when present
@davidzhangmd.bsky.social
#medsky
🔗 tinyurl.com/2w8jpj9r
October 20, 2025 at 6:09 PM
Genetic Associations in Non-Europeans with Pulmonary Fibrosis: Analysis of the All of Us Cohort
Key genetic risk factors of IPF are less prevalent in non-European individuals but confer similar risk of disease when present
@davidzhangmd.bsky.social
#medsky
🔗 tinyurl.com/2w8jpj9r
Key genetic risk factors of IPF are less prevalent in non-European individuals but confer similar risk of disease when present
@davidzhangmd.bsky.social
#medsky
🔗 tinyurl.com/2w8jpj9r
Reposted by David Zhang
This is a big advance, folks. We've never had a disease-modifying drug for this devastating inherited disease
www.science.org/content/arti...
www.washingtonpost.com/health/2025/...
www.economist.com/science-and-...
www.science.org/content/arti...
www.washingtonpost.com/health/2025/...
www.economist.com/science-and-...
September 25, 2025 at 8:13 PM
This is a big advance, folks. We've never had a disease-modifying drug for this devastating inherited disease
www.science.org/content/arti...
www.washingtonpost.com/health/2025/...
www.economist.com/science-and-...
www.science.org/content/arti...
www.washingtonpost.com/health/2025/...
www.economist.com/science-and-...
Reposted by David Zhang
Delighted to share our new study evaluating the association of rare variants in telomere and non-telomere monogenic adult-onset Pulmonary Fibrosis genes and IPF patient survival where we also intersected their effects with #PRS of IPF.
🧬 Rare variants and survival of patients with idiopathic pulmonary fibrosis: analysis of a multicentre, observational cohort study with independent validation
📈 Non-additive effects were seen between qualifying variants and common risk variants in #IPF survival
🔗 www.thelancet.com/journals/lan...
📈 Non-additive effects were seen between qualifying variants and common risk variants in #IPF survival
🔗 www.thelancet.com/journals/lan...
April 29, 2025 at 8:42 AM
Delighted to share our new study evaluating the association of rare variants in telomere and non-telomere monogenic adult-onset Pulmonary Fibrosis genes and IPF patient survival where we also intersected their effects with #PRS of IPF.